Which company was the first to receive FDA approval for a CRISPR-based therapeutic product for human use in the United States?

Scientific breakthroughs often lead to revolutionary products that transform industries. One of the most significant recent advances in biotechnology has been CRISPR gene editing, which has spawned numerous commercial applications. This poll tests your knowledge about how this scientific discovery transitioned from laboratory breakthrough to commercial product development. Understanding the timeline and evolution of such technologies is crucial for those tracking how scientific innovation translates to marketable products.

This is a live public trivia poll on AIPolls.Net. Vote and see real-time results.

Vertex Pharmaceuticals and CRISPR Therapeutics (for CASGEVY/exagamglogene autotemcel)
Editas Medicine (for EDIT-101)
Intellia Therapeutics (for NTLA-2001)
Beam Therapeutics (for BEAM-101)